Tag: FTX Switzerland

Trading Tokenized Stocks And Regulation – FTX v DeFiChain!

Compliance Ben - August 22, 2022

Trading tokenized shares are currently all the rage on crypto exchanges. The aim is to indirectly offer customers trading with traditionally listed shares such as Apple, Microsoft, or Tesla without the intermediation of brokers and low fees. We think tokenized shares also qualify as securities and require a license. While FTX trades tokenized shares through its CySEC-regulated subsidiary K-DNA Financial Services Ltd and other regulated entities, Julian Hosp's DeFiChain operates without regulatory permission. Here's a quick comparison.

Whistleblower Request – Broker Crypto FTX & CySEC-Regulated K-DNA Financial Services!

ASIC Ben - June 19, 2022

We didn't have US crypto billionaire Sam Bankman-Fried and his FTX Group on our radar. This crypto brokerage scheme, controlled via offshore entities in Antigua and Barbuda or the Bahamas, recently acquired CySEC-regulated investment firm K-DNA Financial Services Ltd, led by Martha Lambrianou. In March 2022, FTX Group announced the establishment of FTX Europe AG, Switzerland, as a holding company. FTX Group came to our attention via a BaFin warning against the Investorix broker scam mentioning the K-DNA Financial Services Ltd. We would like to learn more!

FinTelegram is a cyberfinance intelligence and compliance platform investigating financial crime, regulatory violations, and the rails, entities, and ecosystems that facilitate them. Combining investigative journalism, whistleblower intelligence, and forensic compliance analysis, we map risk across payments, banking, crypto, and offshore structures to support transparency, accountability, and informed action.

Disclaimer: FinTelegram is an independent intelligence and compliance platform and does not provide investment, legal, or financial advice. Content published on this website, including references and links to third-party sources, is provided for informational, contextual, and educational purposes only and does not constitute a recommendation, endorsement, or solicitation. Readers must make their own independent assessment and obtain professional advice where appropriate. Past events and referenced materials are not a track record and should not be relied upon as an indicator of future results.